Explore Teva Pharmaceutical Industries (NYSE:TEVA), its pharmaceutical operations, global medicine portfolio, manufacturing ...

Immune dysregulation may contribute to depression, schizophrenia, bipolar disorder, and anxiety through chronic inflammation, ...

Autoantibodies are central to the diagnosis, classification, and stratification of many autoimmune diseases, particularly ...

Almost a year after President Trump authorized preemptive law enforcement measures based on political or ideological beliefs, ...

From heart attack recovery to preventive healthcare, studies are showing how yoga can complement modern medicine and expand access to affordable care.

Scientists are getting closer to figuring out how amyloid immunotherapy causes ARIA, and perhaps how to prevent it. At last month’s AD/PD conference in Copenhagen, Denmark, the spotlight was on innate ...

Complement component 3, often called C3, is an essential protein of the immune system. This protein plays a vital role in the body’s innate immune system, providing the first line of defense against ...

A complement C4 (also known as a complement component 4, or simply C4) is a test to measure the level of C4 proteins you have in your blood. These proteins play a role in how your immune system ...

Yoga significantly aids people with opioid use disorders (OUD), according to recent results published online ahead of print in JAMA Psychiatry. The data were collected from a randomized clinical trial ...

SAN FRANCISCO -- The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The ...

Antiamyloid therapies for Alzheimer disease recently entered clinical practice, making imaging biomarkers for Alzheimer disease even more relevant to guiding patient management. Amyloid and tau PET ...

-- Interim Analysis Data from Ongoing Phase 2 Study of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Selected for Podium Presentation -- SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) ...